💨 Abstract
Zydus Lifesciences, an Indian pharmaceutical company, has received USFDA approval to manufacture Niacin Extended-Release Tablets in the US. These tablets are used to manage cholesterol levels and reduce the risk of heart attacks. The tablets will be produced at the company's Ahmedabad manufacturing site.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
JBM Electric Vehicles Partners Hitachi ZeroCarbon to Accelerate the Transition to Clean Public Transport in India
CM Rekha Gupta directs DJB for revamp of city's water, sewage infra
'Einstein' drama starring Matthew Gray Gubler delayed to 2026-27 season
Stand by govt on combatting terror, war no solution: CPI MP
Exicom Unveils the Tritium TRI-FLEX to Enable Ultra-Scaling of EV Charging Infrastructure
SWITCH Mobility Flags Off 100 SWITCH IeV3 for Waste Management to Indore, boosting city's sustainability efforts
Eagle Cargo has helped brands ZROTAX Property Investment Dubai - Point Blank Halff Grey and Re/do Beauty
Courts can modify arbitral awards, SC holds in majority verdict
Israeli private eye loses extradition fight over US 'hack and leak' charges
Govt revamps National Security Advisory Board, appoints ex-R&AW chief Alok Joshi its chairman
Powered by MessengerX.io